Fulminant myocarditis with myositis after treatment with immune checkpoint inhibitors

被引：0
作者：
Vargas-Osorio, K. [1 ]
Prada Ramallal, G. [1 ]
Gonzalez-Ferrero, T. [2 ]
Cameselle-Teijeiro, J. M. [1 ,3 ,4 ]
机构：
[1] Clin Univ Hosp Santiago, Pathol Serv, La Coruna, Spain
[2] Univ Hosp Lucus Augusti, Serv Cardiol, Lugo, Spain
[3] Hlth Res Inst Santiago de Compostela IDIS, La Coruna, Spain
[4] Univ Santiago de Compostela, Dept Pathol, La Coruna, Spain
来源：
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY | 2024年 / 135卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
12
引用
收藏
页码：26 / 27
页数：2
相关论文
共 50 条
[41]   Encephalomyeloneuritis and arthritis after treatment with immune checkpoint inhibitors [J].
Nowosielski, Martha ;
Di Pauli, Franziska ;
Iglseder, Sarah ;
Wagner, Michaela ;
Hoellweger, Nicole ;
Van Anh Nguyen ;
Gruber, Johann ;
Stockhammer, Guenther .
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION, 2020, 7 (04)
[42]   Myocarditis Associated With Immune Checkpoint Inhibitors in Patients With Thymoma [J].
Cooper Jr, Leslie T. ;
Wolf, Robert A. ;
Plautz, Greg E. ;
Kratt, Christine ;
Lalchandani, Varsha B. ;
Bond, T. Christopher .
JACC-ADVANCES, 2023, 2 (06)
[43]   Myocarditis: Uncommon but severe toxicity of immune checkpoint inhibitors [J].
Courand, Pierre-Yves ;
Bouali, Anissa ;
Harbaoui, Brahim ;
Cautela, Jennifer ;
Thuny, Franck ;
Lantelme, Pierre .
BULLETIN DU CANCER, 2019, 106 (11) :1050-1056
[44]   Myasthenia gravis, myositis and myocarditis: a fatal triad of immune-related adverse effect of immune checkpoint inhibitor treatment [J].
Soman, Biji ;
Dias, Maria Cecilia ;
Rizvi, Syed Azhar J. ;
Kardos, Attila .
BMJ CASE REPORTS, 2022, 15 (12)
[45]   Successful treatment of immune checkpoint inhibitor-associated fulminant myocarditis with abatacept and ruxolitinib: a case report [J].
Wadden, Elena ;
Lai, Carol ;
Grivas, Petros ;
Bhatia, Shailender ;
Portuguese, Andrew J. ;
Salem, Joe-Elie ;
Moslehi, Javid J. ;
Cheng, Richard K. .
EUROPEAN HEART JOURNAL-CASE REPORTS, 2025, 9 (02)
[46]   Fulminant myocarditis with myositis of ocular and respiratory muscles [J].
Hiraiwa, Hiroaki ;
Furusawa, Kenji ;
Kazama, Shingo ;
Kimura, Yuki ;
Shibata, Naoki ;
Arao, Yoshihito ;
Oishi, Hideo ;
Kato, Hiroo ;
Kuwayama, Tasuku ;
Yamaguchi, Shogo ;
Kondo, Toru ;
Sawamura, Akinori ;
Morimoto, Ryota ;
Okumura, Takahiro ;
Murohara, Toyoaki .
NAGOYA JOURNAL OF MEDICAL SCIENCE, 2020, 82 (03) :585-593
[47]   FULMINANT MYOCARDITIS AS A COMPLICATION OF SCLERODERMA PATIENTS WITH MYOSITIS [J].
KERR, LD ;
SPIERA, H .
ARTHRITIS AND RHEUMATISM, 1992, 35 (09) :S237-S237
[48]   Troponin Kinetics and Cardiovascular Events in Patients With Myocarditis After Immune Checkpoint Inhibitors Use [J].
Silva, Thiago ;
Drobni, Zsofia ;
Zafar, Amna ;
Gongora, Carlos ;
Zubiri, Leyre ;
Zlotoff, Daniel ;
Gong, Jingyi ;
Lee, Charlotte ;
Hartmann, Sarah ;
Gilman, Hannah ;
Villani, Alexandra-Chloe ;
Sullivan, Ryan ;
Reynolds, Kerry ;
Zhang, Lili ;
Nohria, Anju ;
Neilan, Tomas .
CIRCULATION, 2021, 144
[49]   Fulminant Immune-mediated Myocarditis in a Metastatic Cancer Patient on Combination Therapy of TIGIT and PD-1 Immune Checkpoint Inhibitors [J].
Fallahi, Sara ;
Kraus, Samuel ;
Abdelaziz, Ahmed ;
Parks, Bruce .
LABORATORY INVESTIGATION, 2024, 104 (03) :S12-S13
[50]   IMMUNE CHECKPOINT INHIBITOR-RELATED MYASTHENIA GRAVIS, MYOSITIS, HEPATITIS, AND MYOCARDITIS [J].
Pham, Phuoc ;
Heppler, Miranda ;
Jackson, Ian P. ;
Plambeck, Robert W. .
CHEST, 2024, 166 (04) :5381A-5382A
12345